| Product Code: ETC5242416 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Republic of North Macedonia continues to show strong growth in aminoglycosides import shipments, with top exporting countries including India, China, and Spain. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market in 2024, while the impressive compound annual growth rate (CAGR) of 21.39% from 2020-24 illustrates sustained expansion. Additionally, the growth rate of 8.09% from 2023-24 suggests continued positive momentum in the aminoglycosides import market in North Macedonia.

North Macedonia's Aminoglycosides market is anticipated to experience a growing growth rate of 9.60% by 2027, reflecting trends observed in the largest economy Germany, followed by United Kingdom, France, Italy and Russia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Macedonia Aminoglycosides Market Overview |
3.1 Republic of Macedonia Country Macro Economic Indicators |
3.2 Republic of Macedonia Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Macedonia Aminoglycosides Market - Industry Life Cycle |
3.4 Republic of Macedonia Aminoglycosides Market - Porter's Five Forces |
3.5 Republic of Macedonia Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Republic of Macedonia Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Republic of Macedonia Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Republic of Macedonia Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Republic of Macedonia |
4.2.2 Growing awareness about the effectiveness of aminoglycosides in treating severe infections |
4.2.3 Rising healthcare expenditure and investments in healthcare infrastructure in the region |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for the use of aminoglycosides in healthcare settings |
4.3.2 Increasing concerns about antibiotic resistance and associated risks |
5 Republic of Macedonia Aminoglycosides Market Trends |
6 Republic of Macedonia Aminoglycosides Market Segmentations |
6.1 Republic of Macedonia Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.3 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.4 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.5 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.6 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.7 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 Republic of Macedonia Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 Republic of Macedonia Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 Republic of Macedonia Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 Republic of Macedonia Aminoglycosides Market Import-Export Trade Statistics |
7.1 Republic of Macedonia Aminoglycosides Market Export to Major Countries |
7.2 Republic of Macedonia Aminoglycosides Market Imports from Major Countries |
8 Republic of Macedonia Aminoglycosides Market Key Performance Indicators |
8.1 Rate of hospital-acquired infections in Republic of Macedonia |
8.2 Number of healthcare facilities adopting aminoglycosides in their treatment protocols |
8.3 Percentage of healthcare professionals trained in the appropriate use of aminoglycosides |
9 Republic of Macedonia Aminoglycosides Market - Opportunity Assessment |
9.1 Republic of Macedonia Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Republic of Macedonia Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Republic of Macedonia Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Republic of Macedonia Aminoglycosides Market - Competitive Landscape |
10.1 Republic of Macedonia Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Republic of Macedonia Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here